Inventor
DHATRAK CHANDRAKANT
IN15 patents
⚠️ This page may combine multiple inventors who share the name “DHATRAK CHANDRAKANT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLENMARK SPECIALTY SA
13 patentsUS9750754B2Sep 5, 2017
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA6 citations82
US9987260B2Jun 5, 2018
Tiotropium inhalation solution for nebulization
GLENMARK SPECIALTY SA5 citations81
US9757365B2Sep 12, 2017
Tiotropium inhalation solution for nebulization
GLENMARK SPECIALTY SA6 citations70
US12303635B2May 20, 2025
Dispensing device and pharmaceutical composition for the treatment of rhinitis
GLENMARK SPECIALTY SA1 citations62
US11679210B2Jun 20, 2023
Dispensing device and pharmaceutical composition for the treatment of rhinitis
GLENMARK SPECIALTY SA1 citations60
US9937189B2Apr 10, 2018
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA1 citations60
US10765686B2Sep 8, 2020
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10561672B2Feb 18, 2020
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10517880B2Dec 31, 2019
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10376526B2Aug 13, 2019
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10653683B2May 19, 2020
Tiotropium inhalation solution for nebulization
GLENMARK SPECIALTY SA0 citations49
US10632108B2Apr 28, 2020
Tiotropium inhalation solution for nebulization
GLENMARK SPECIALTY SA0 citations49
US10632109B2Apr 28, 2020
Tiotropium inhalation solution for nebulization
GLENMARK SPECIALTY SA0 citations49